| (19) |
 |
|
(11) |
EP 0 272 551 A3 |
| (12) |
EUROPEAN PATENT APPLICATION |
| (88) |
Date of publication A3: |
|
09.05.1990 Bulletin 1990/19 |
| (43) |
Date of publication A2: |
|
29.06.1988 Bulletin 1988/26 |
| (22) |
Date of filing: 10.12.1987 |
|
| (51) |
International Patent Classification (IPC)4: A61L 2/18
// A61J1/00 |
|
| (84) |
Designated Contracting States: |
|
AT BE CH DE ES FR GB GR IT LI NL SE |
| (30) |
Priority: |
22.12.1986 US 944061
|
| (71) |
Applicant: MILES INC. |
|
Elkhart
Indiana 46514 (US) |
|
| (72) |
Inventors: |
|
- Champion, Alexander B.
Albany
California 94706 (US)
- Collins, Michael S.
Pinole
California 94564 (US)
|
| (74) |
Representative: Adrian, Albert, Dr. et al |
|
Bayer AG
Konzernverwaltung RP
Lizenzen und Technische Kooperationen
51368 Leverkusen
51368 Leverkusen (DE) |
|
| |
|
| (54) |
An improved blood bag system incorporating quinolone carboxylic acid derivatives |
(57) A method and system is disclosed for introducing antibacterial agents, for example,
quinolone carboxylic acid derivatives into blood bag systems for preventing massive
bacteria growth in stored blood and blood components. The quinolone carboxylic acid
derivative can be added to a collection container before, during or after the collection
of blood and blood components. The addition of a quinolone carboxylic acid derivative
to blood bag systems allows for increase in storage time for blood and blood components
without the threat of massive bacterial contamination.